| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.32 | 0.06 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.093 | 0.07 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |